McKesson
About: McKesson Corp is one of three leading pharmaceutical wholesalers in the us engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the us pharmaceutical wholesale industry. Outside the us market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Employees: 51,000
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
141% more first-time investments, than exits
New positions opened: 239 | Existing positions closed: 99
44% more call options, than puts
Call options by funds: $1.12B | Put options by funds: $774M
16% more capital invested
Capital invested by funds: $54.9B [Q3] → $63.5B (+$8.61B) [Q4]
9% more funds holding in top 10
Funds holding in top 10: 33 [Q3] → 36 (+3) [Q4]
7% more funds holding
Funds holding: 1,519 [Q3] → 1,619 (+100) [Q4]
2.19% less ownership
Funds ownership: 86.29% [Q3] → 84.1% (-2.19%) [Q4]
12% less repeat investments, than reductions
Existing positions increased: 539 | Existing positions reduced: 615
Research analyst outlook
4 Wall Street Analysts provided 1 year price targets over the past 3 months
4 analyst ratings
Wells Fargo Stephen Baxter 32% 1-year accuracy 12 / 37 met price target | 3%upside $691 | Equal-Weight Maintained | 14 Mar 2025 |
Evercore ISI Group Elizabeth Anderson 52% 1-year accuracy 17 / 33 met price target | 1%upside $675 | Outperform Maintained | 6 Feb 2025 |
Citigroup Daniel Grosslight 43% 1-year accuracy 10 / 23 met price target | 1%upside $677 | Buy Maintained | 10 Jan 2025 |
B of A Securities Michael Cherny 68% 1-year accuracy 19 / 28 met price target | 3%downside $650 | Buy Maintained | 6 Jan 2025 |
Financial journalist opinion
Based on 11 articles about MCK published over the past 30 days
